Document is current
Any future updates will be listed below
-
Authors
Cragg, Liza
Williams, Siân
van der Molen, Thys
Thomas, Mike
Correia de Sousa, Jaime https://orcid.org/0000-0001-6459-7908
Chavannes, Niels H. https://orcid.org/0000-0002-8607-9199
- License Information
-
More Information
Article History
Received: 8 December 2016
Revised: 26 January 2018
Accepted: 29 January 2018
First Online: 8 March 2018
Competing interests
: Mike Thomas in the last 3 years has received speaker’s honoraria for speaking at sponsored meetings or satellite symposia at conferences from the following companies marketing respiratory and allergy products: Aerocrine, AstraZeneca, Boehringer Inglehiem, GSK, MSD, Teva. Novartis. He has received honoraria for attending advisory panels with; Aerocrine, Almirall, AstraZeneca, BI, Chiesi, GSK, MSD, Novartis. He has received sponsorship to attend international scientific meetings from: GSK, AstraZeneca. He has received funding for research projects from: GSK. He is a member of the BTS SIGN Asthma guideline group and the NICE Asthma guideline group. Jaime Correia de Sousa received sponsorships from, or delivered consultancy services to AstraZeneca, GSK, MSD, Novartis, and Boehringer Ingelheim. Thys van der Molen in the last 3 years has received speakers’ honoraria and advisory board honoraria from AstraZeneca, GSK, Boehringer Ingelheim and TEVA. He has received funding for research projects from AstraZeneca and GSK. From June 2017 he is a GSK employee. The remaining authors declare no competing financial interests.
